Author: GlobeNewswire

SUNNYVALE, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research…

PRESS RELEASE December 28, 2021 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced the initiation…

TORONTO, Dec. 28, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”),…

FORT WORTH, TX, Dec. 28, 2021 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a provider…

RENO, Nev., Dec. 28, 2021 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing…

HiFiViral Solution helps to accelerate understanding of the Omicron variant, providing information that is important to public health responseMENLO PARK,…

STOUGHTON, Mass., Dec. 28, 2021 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being…

MALVERN, Pa., Dec. 28, 2021 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on commercializing…

DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing,…

HAMILTON, Bermuda, Dec. 28, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio…